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Reactive oxygen species (ROS) play a vital role in cell signaling and redox regulation, but when
present in excess, lead to numerous pathologies. Detailed quantitative characterization of
mitochondrial superoxide anion (O 
2 Þ production in fetal pulmonary artery endothelia cells
(PAECs) has never been reported. The aim of this study is to assess mitochondrial O 
2 production in cultured PAECs over time using a novel quantitative optical approach. The rate, the
sources, and the dynamics of O 
2 production were assessed using targeted metabolic modulators
of the mitochondrial electron transport chain (ETC) complexes, speci¯cally an uncoupler and
inhibitors of the various ETC complexes, and inhibitors of extra-mitochondrial sources of O 
2 .
After stabilization, the cells were loaded with nanomolar mitochondrial-targeted hydroethidine
(Mito-HE, MitoSOX) online during the experiment without washout of the residual dye. Timelapse °uorescence microscopy was used to monitor the dynamic changes in O 
2 °uorescence
intensity over time in PAECs. The transient behaviors of the °uorescence time course showed
exponential increases in the rate of O 
2 production in the presence of the ETC uncoupler or
inhibitors. The most dramatic and the fastest increase in O 
2 production was observed when the
cells were treated with the uncoupling agent, PCP. We also showed that only the complex IV
inhibitor, KCN, attenuated the marked surge in O 
2 production induced by PCP. The results
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showed that mitochondrial respiratory complexes I, III and IV are sources of O 
2 production
in PAECs, and a new observation that ROS production during uncoupling of mitochondrial respiration is mediated in part via complex IV. This novel method can be applied in other studies that
examine ROS production under stress condition and during ROS-mediated injuries in vitro.
Keywords: Fluorescence microscopy; time-lapse imaging; oxidative stress; superoxide;
pentachlorophenol sodium salt; rotenone; antimycin A; potassium cyanide; MitoSOX.
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1. Introduction
Reactive oxygen species (ROS) are biologically important molecules. They are involved in signaling,
but when present in excess (oxidative stress), they
exert deleterious e®ects on cell structure and function. Cellular ROS are produced in mitochondria
and from non-mitochondrial sources, including the
NADPH oxidase (NOX) system and uncoupled
endothelial nitric oxide synthase (eNOS). Mitochondrial ROS are generated primarily during
electron transfer along the electron transport chain
(ETC) complex proteins. Of all the cellular sources
of ROS, electron leakage from the ETC to O2
(dioxygen) is responsible for a steady °ux of
superoxide (O 
2 Þ anions, which makes mitochondria the major site of the primordial ROS production.1–4 Under physiological conditions, small
amounts of ROS are generated due to partial re4–6
The major areas
duction of O2 into O 
2 anion.

for electron leak leading to O 2 production includes
°avins and quinones of the ETC complexes, and
this is more prominent under conditions that decrease electron transfer to complex IV, the terminal
electron acceptor.4
Physiological ROS are maintained at acceptable
levels by endogenous matrix of antioxidant defense
mechanisms. In this case, the O 
2 anions are readily
dismutated to other radical species, such as hydrogen peroxide (H2O2) and sometimes to the more
reactive hydroxyl radicals (OH  Þ4 by mitochondrial
manganese superoxide dismutase (MnSOD) and
other enzymatic reactions.4,6 Therefore, since O 
2 is
the precursor of most of the downstream ROS and it
is also involved in the propagation of oxidative
stress-mediated damages, it has become an important biomarker to assess oxidative damage of key
macromolecules.6,7
There is an expanding body of evidence that
ROS participate in numerous cell signaling
mechanisms, and are widely implicated in the pathologies of cellular and tissue injury.8–15

Understanding and discerning the role of ROS
depends on the ability to measure and quantify the
dynamics of mitochondrial ROS production under
normal and stress conditions. A variety of metabolic
modulators of mitochondria, such as ETC uncouplers and inhibitors, as well as metabolic stress
conditions, for example, hyperoxia and hypoxia
(O2 stress), lead to altered mitochondrial ROS
production.16–19
MitoSOX Red, a °uorescence probe, and a
derivative of Hydroethidine (HE), is a widely used
probe for mitochondrial-targeted O 
2 detection in
cultured cells.14 The positive charge on the phosphonium group in MitoSOX Red selectively targets
this cell-permeant HE derivative to mitochondria.20
Once in mitochondria, MitoSOX is oxidized
and the product elicits °uorescence
by O 
2
20,21
response
proportional to O 
2 concentration. In
numerous studies, MitoSOX use was validated with
°uorescent microscopy21–30 for selective detection of
24,25,31
mitochondrial O 
cardi2 in endothelial cells,
24,29
30
¯broblasts,
and
neuronal
omyocytes,
cells.21,27,28 However, none of these studies used realtime monitoring of mitochondrial O 
2 production.
Therefore, we aimed to develop a simple and quantitative method for simultaneous detection of
mitochondrial O 
2 production in a large population
of cultured cells using the mitochondrial O 
2 sensitive membrane permeable MitoSOX Red. To the
best of our knowledge, we show for the ¯rst time that
time-lapse microscopy in combination with nanomolar MitoSOX compartmentalized in mitochondria
can be used to quantitatively measure mitochondrial
O 
2 production in live healthy and diseased cells, in
real-time. The other novelty of this study is localizing
the primary source of O 
2 under stress conditions
using the proposed dual agent protocol.
Since O 
2 is the primordial ROS, we devoted our
e®ort in this study to monitor and quantify the
dynamic changes in O 
2 production during modulation of ETC activities in PAEC, which to date has
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not been reported. Our method was based on the
PAEC model and the use of modulators of the ETC;
inhibitors: rotenone (complex I), antimycin A
(complex III) and KCN (complex IV) and the ETC
uncoupler, PCP. To further ascertain that O 
2
anions are primarily of mitochondrial source, the
SOD mimetics, MitoTempol was used during the
perturbation of mitochondrial ETC function.
Addition of the metabolic agents induced metabolic
stress that led to dynamic changes in the rate of
O 
2 production over time. It is worth noting that in
other cell types, especially nonexcitable cells like
PAEC, other sources of ROS production, for example, NOX could contribute to the total O 
2
production during simulated metabolic/hypoxic
stress. Therefore, additional experiments were conducted using apocynin to assess potential ROS
production from NOX sources. Overall, the use of
time-lapse microscopy provides an ideal approach
to study the spatial and temporal changes in mitochondrial O 
2 production in real-time during metabolic stress in live cells. This method not only
assesses the O 
2 production from the ETC, but also
localizes the source of ROS in mitochondria and
extra-mitochondrial sources. Lastly, the application
of this approach is not limited to studying dynamic
ROS production in real-time in PAECs, it can be
used in other types of cells under normal and
pathophysiological conditions.

2. Materials and Methods
2.1. Cell preparation
PAECs from normotensive fetal lambs (NFL) were
isolated and characterized using techniques we described previously.32,33 Isolated PAECs were cultured in DMEM (Life Technologies) with 20% FBS
(Life Technologies) and 1X antibiotic/antimycotic (Life Technologies) at 37  C in 21% O2, 5%
CO2, balance N2. PAECs between passages 3 and 4
were used for our experiments, and were cultured
(104 cells/well) in 4-well chamber slides (Lab-Tek,
VCAT) and kept in the incubator (21% O2, 5%
CO2, 74% N2 Þ at 37  C before imaging. At the onset
of each experiment and °uorescent imaging, the
cells were loaded with 200 nM Hoechst (Life Technologies H1399, excitation/emission: UV/blue) in
2 ml growth medium to stain the nuclei and then
incubated for 30 min before imaging. Following
incubation, the cells were washed twice, and Hank's

Balanced Salt Solution (HBSS, Life Technologies
14025092) was added to the dish for subsequent
°uorescent imaging. During the imaging, mitochondrial O 
2 production was visualized in intact
cultured PAECs loaded with a mitochondrialtargeted dihydroethidium (Mito-HE), red °uorescence probe (MitoSOX 500 nM, Invitrogen M36008;
excitation/emission: 510/580 nm). Once in the miand
tochondria, MitoSOX is oxidized by O 
2
exhibits a red °uorescent response proportional to
the O 
2 level.

2.2.
2.2.1.

Live cell time-lapse imaging
MitoSOX loading

Production of O 
2 in live cells was visualized by
MitoSOX Red, a triphenylphosphonium (TPP þ Þlinked DHE compound. It is preferentially attracted
to the mitochondria by > 100-fold compared with
the cytosol34 due to the strong negative mitochondrial membrane potential (m). In mitochondria,
the accumulated MitoSOX is oxidized by O 
2 and
the product exhibits °uorescence upon binding to
mitochondrial DNA.20,21 The high matrix
concentration of MitoSOX also allows the dye to
compete with the endogenous mitochondrial O 
2
35,36
scavenger, MnSOD, for O 
2 .
For the time lapse monitoring of the O 
2
production, MitoSOX loading was performed online
while the experiment was running in the microscope
chamber environment. To maintain a high intramitochondrial concentration of MitoSOX, the
loading process was not followed by washout of
residual dyes. This approach is to ensure that the
MitoSOX concentration (nM) in mitochondria is
high enough to compete with MnSOD for O 
2 .
allows
for
Ongoing binding to mitochondrial O 
2
real-time monitoring of the MitoSOX oxidation
rate, which re°ects O 
2 concentration and rate of
production over time.

2.2.2.

Fluorescent microscopy

Live cells were imaged using a Nikon Ti-E inverted
microscope, with four °uorescent interchangeable
¯lter cubes in addition to the standard DIC and
bright-¯eld channels. The bright ¯eld images were
acquired using an overhead halogen lamp, whereas
the °uorescent images used a mercury arc lamp, to
take advantage of its intense peaks in the ultraviolet
range. Each image was acquired at a magni¯cation
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of 20  with a scale of 0.32 m per pixel. The images
were captured using a charge-coupled device camera
(Q-imaging, Aqua Exi, 14 bit, 6.45 m per pixel)
with exposure time (0.68 s/pixel in red channel)
set to ensure proper use of the dynamic range of the
camera, while avoiding saturation and photo
bleaching. The ¯lter set in the blue and red channels
¯lters excitation spectra at 340–380 nm and 528–
553 nm, respectively with emission spectra at 435–
485 nm and 590–650 nm, respectively.2
Time-lapse images were obtained in the blue
(Hoechst), red (MitoSOX), and bright ¯eld (BF)
channels to monitor nuclei, mitochondrial ROS
levels and the structure of the cells, respectively.
Four ¯elds of view (FOV) of cells were imaged
(one FOV in each chamber of the bottom-glass
dish) under the aforementioned settings. The microscope is surrounded by a custom-made chamber
(Okolab) housed around the stage, providing gas
exchange and controlled temperature for time-lapse
imaging over several hours. During the experiments,
the level of the CO2 inside the chamber was maintained at 5% by mixing CO2 with room air at the
proper ratio and chamber temperature was kept at
37  1 (SE)  C. O2 and CO2 levels were continuously monitored with an O2-BTA model O2 sensor
and CO2-BTA model CO2 probe (Vernier Co.,
Beaverton, OR).

2.2.3. Co-localization
Z-stacks of green and red images of 20 randomly
selected PAECs previously stained with Mitotracker green (50 nM) and loaded online with
MitoSOX red (500 nM) were acquired. The nuclear
region of each cell image in z-stacks was excluded
using the nuclear mask obtained in blue channel.
Co-localization analysis was performed by pseudocoloring and merging green and red °uorescence
images together. Both °uorophores resided within
the same 3D volume whose minimum size is de¯ned
by the resolution limits of the microscope (0.32 m
at a magni¯cation of 20 ). Quantitative statistical
analyses of both the spatial distribution and the
correlation between the intensities of the green and
red °uorescence images were performed to measure
co-localization. Co-localization was determined by
quanti¯cation of overlapping channels, performed
by using the \object-based methods" algorithm
of JACoP plugin V2.0.37

2.2.4.

Experimental protocols

Our experimental protocol was designed to measure
changes in mitochondrial O 
2 production associated with metabolic stress conditions as a model of
ROS production in PAECs. Time-lapse images of
FOV were captured in blue, red, and bright ¯eld
channels, all in 1-min intervals for 80 min. Ten
minutes of baseline imaging was followed by the
addition of MitoSOX (500 nM) to the PAECs.
Imaging was continued for 20 min after the
addition of MitoSOX. Then the cells were treated
with metabolic stressors, including pentachlorophenol sodium salt (PCP, ETC uncoupler, 15 M,
Sigma Alrich #76480), rotenone (Complex I inhibitor, 15 M, Sigma Alrich #R8875), antimycin A
(Complex III inhibitor, 1 M, Sigma Aldrich
#A8674), or potassium cyanide (KCN, complex IV
inhibitor, 20 M, Sigma Aldrich #60178) to study
production in the mitochondria as indithe O 
2
cated by °uorescence intensity. The aforementioned
concentrations of these mitochondrial modulators
were chosen based on dose response studies, with
the goal of achieving su±cient inhibition or
uncoupling (data not shown) while minimizing their
toxic e®ect as shown in the cell viability studies.
Image acquisition continued for 50 min after adding
the stressors. These agents also provide means to
validate mitochondrial O 
2 production in PAECs
during online assessment of MitoSOX oxidation
based on our experimental protocol.
To demonstrate the feasibility of our method to
localize the source of mitochondrial O 
2 under the
metabolic stress conditions, dual agents (a combination of metabolic modulators) experimental protocols were designed. For instance, 5 min after
initiation of uncoupling induced by the addition
of PCP, a metabolic inhibitor (rotenone (ROT),
antimycin A (AA) or KCN) was administered. This
approach was to identify the speci¯c ETC complexes associated with the large increase in mitochondrial O 
2 production during uncoupling (PCP)
of mitochondrial respiration. Fluorescent recording
was for 50 min after adding the second metabolic
agent/modulator. The dual agent experimental
protocol was also helpful to validate mitochonproduction with real-time monitoring
drial O 
2
of MitoSOX oxidation using positive controls (uncoupler or inhibitor) as ¯rst agent and negative
control (MitoTempol) as second agent.

1750018-4
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Viability of PAECs treated with MitoSOX only,
MitoSOX and PCP, MitoSOX and PCP and KCN
was assessed by trypan blue exclusion assay.38
Furthermore, additional experiments revealed that
none of the mitochondrial modulators at the used
concentrations interfered with MitoSOX °uorescent
emission signal.

2.3.
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2.3.1.

Image and signal processing
Cell segmentation

linear ¯t of the intensity pro¯les was calculated in
the MitoSOX interval (t ¼ 11–29 min) for both
control and treated groups. The MitoSOX-interval
slope of the cell intensity pro¯le in both control (no
treatment) and treated groups were calibrated
based on the MitoSOX-interval slope of a control in
such a way that their slopes at this interval and
before adding a metabolic agent were the same; the
di®erence in the slopes of the control and treated
groups were distinguishable after adding the agent.
Therefore, the resulting intensity pro¯les are

Our previously reported cell segmentation algorithm39 was used to detect the border of the cells in
the bright ¯eld images. The obtained mask (cells
contours) was applied to the time-lapse image stack
in the red °uorescent channel. The nuclei were also
identi¯ed in the blue images and the resulting blue
binary image was used as a mask for the stack of
the red images to exclude the nuclei contribution to
the red intensity pro¯les. The mean intensity of the
mitochondria in red channel images was calculated
as a raw intensity pro¯le of the live PAECs over
time. This pro¯le helps to monitor the dynamics of
the mitochondrial ROS production before, during
and after altering ETC function.
Intensity pro¯le
Figure 1 represents the overall methodology to obtain ¯nal intensity pro¯les of the cells from the
input °uorescent images. Intensity pro¯le of the red
°uorescence images shows the dynamic of O 
2
production in response to MitoSOX (t ¼ 10 min)
and metabolic agents (t ¼ 30 min). In order to
quantify the dynamic changes in mitochondrial O 
2
levels and compare the changes in O 
2 production
between the control group (PAECs with MitoSOX,
i.e., no treatment) and treated groups (PAECs
treated with inhibitors or/and the uncoupler), the
raw intensity pro¯les were ¯rst background subtracted and then slope calibrated. Day-to-day variation of light intensity and illumination pattern led
to variations in the basal level intensity, which was
accounted for background subtraction. A linear
scaling, slope calibration method, which preserve
the slope ratio (SR), was employed for better
demonstration and comparison. The slope calibration was done in the single agent/modulator
experiments, using the linear property of the
MitoSOX-induced intensity rate (for 20 min interval after administration of MitoSOX and before
addition of the metabolic agent). The slope of the

Fig. 1. A schematic illustration of the methodology used to
obtain the MitoSOX °uorescent intensity pro¯les of the cells
from the input °uorescent images. The schematic °ow chart
shows the same approach for a typical single or dual agent
experiment.
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visually comparable for control and treated groups
in the time interval of t ¼ 30–80 min, which is
helpful to evaluate the e®ect of the metabolic agent
on the intensity pro¯le. As mentioned earlier, for
the dual agent experiments, the second agent, rotenone, antimycin A or KCN was administrated 5
mins after addition of PCP. Since the objective of
the dual agent experiments is the evaluation of the
inhibitor e®ect in the presence of the PCP, the slope
calibration was applied based on the PCP-interval
slope (t ¼ 33–35 min) in such a way that their
slopes at this interval and therefore before adding
the second agent were the same. The resulting
intensity pro¯les of the dual agent groups were
compared to the °uorescent intensity pro¯les of
the PCP only group in the time interval of t ¼ 35–
80 min, to evaluate the e®ects of ETC inhibitors
(ROT, AA and KCN) on the rate of °uorescent
change after maximally oxidizing the ETC
with PCP.

2.4.

Quanti¯cation of the kinetics
of superoxide production

Exponential and sigmoidal empirical functions were
used for quantitative description of the red °uorescence time-intensity curves measured in treated
and control cells, respectively.
I1 ðtÞ  aþb  e  T ;
c
I2 ðtÞ 
t30 :
1 þ de  
t30

ð1Þ
ð2Þ

For the exponential function (Eq. (1)), the parameters are amplitude (b in F.A.U.), time constant
(T in min), and the constant intensity o®set (a in
F.A.U.). For the sigmoidal function (Eq. (2)), the
parameters are amplitude (c in F.A.U.), time constant ( in min), and the displacement factor d.
These parameters were estimated by ¯tting
(MATLAB, MathWorks, Inc. Massachusetts 01760
USA) Eqs. (1) or (2) to the red °uorescence timeintensity pro¯les from treated, and control groups,
respectively.
The estimated values of the above parameters can
be used to quantify the initial surge in O 
2 production in the presence and absence of metabolic
agents/modulators. For instance, the parameter
cd
groups b
T and ¿ ð1þdÞ 2 are measures of the initial rates
(F.A.U. per min) of O 
2 production in the presence
and absence of the metabolic agents, respectively.

2.5.

Statistical analysis

Data are shown as means  SE. Student's t-test
was used for normally distributed data. A p value
< 0:05 was considered signi¯cant.

3.

Results

Co-localization of MitoTracker green signal with
the MitoSOX red signal in PAECs con¯rmed that
anions were produced from mitochondria in
O 
2
cells exposed to metabolic stress conditions. The
degree of co-localization of these two °uorescent
signals in the PAECs was 0.91  0.06, indicating
signi¯cant mitochondrial localization of the O 
2
production.
Viability of PEACs treated with MitoSOX
only, MitoSOX plus PCP, and MitoSOX plus PCP
and KCN was assessed at the end of the 80 min
experimental protocol. The percentages of cells
that were viable following the aforementioned
treatments were: 88  2%, 76  3%, and 80  3%,
respectively.
The top panel in Fig. 2(a) displays red °uorescent images of PAECs, from which, intensities were
translated to the rate of O 
2 production in mitochondria. The ¯rst row is the control (CTRL)
group, the second and third rows are cells with the
addition of an uncoupler (PCP), and an inhibitor
(KCN), respectively. The ¯rst column of images is
the ¯rst frame of the time-lapse imaging (t ¼ 0 min)
showing the FOV of interest with no contrast
between cells and background. The second column
of images shows the same FOV just before adding
the uncoupler or inhibitor at time t ¼ 30 min. The
addition of the agents enhances the contrast between cells and background due to increasing O 
2
production in mitochondria, as evidenced by the
increased MitoSOX (added at t ¼ 10 min) °uorescent signal. Compared to the second column, the
third column images show the frames (at time
t ¼ 60 min) with slight increase in the intensity in
the ¯rst row (CTRL group), and signi¯cant increase
in intensity in the second and third rows due to
exponential increase in O 
2 production after adding
KCN and PCP, respectively. The last column of
images shows the frames at t ¼ 80 min demonstrating larger increase in O 
2 production rate in
the control group (¯rst row), and smaller increase
production in the treated groups (second
in O 
2
and third rows). These observations are consistent
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(a)

(b)
Fig. 2. Panel (a) representative raw frames from image stack of time-lapse microscopy showing dynamic O 
2 production in three
experiments using live PAEC loaded with MitoSOX in control (no treatment), in the presence of complex IV inhibitor (KCN) or the
uncoupler PCP. Elapsed time is indicated in the upper left corner of each frame (0, 30, 60 and 80 min). Note that the scale bar in the
right corner of the right bottom frame is the same for all frames and is 32 m. Panel (b) representative dynamic recordings of mean
°uorescence intensity pro¯les of the cells in the three aforementioned conditions. The blue curve displays the dynamic of the
°uorescence intensity in control cells over time; the green and purple curves represent the °uorescence intensity in cells treated with
PCP and KCN, respectively. The arrows indicate the time MitoSOX and agents were added to the cells. F.A.U., °uorescence
arbitrary unit; KCN, potassium cyanide; PCP, pentachlorophenol sodium salt.

with the °uorescent intensity pro¯les demonstrated
in panel (b). Figure 2(b) shows the corresponding
quantitative changes in the °uorescence intensity in
the cell after calibration. Inhibiting and uncoupling
mitochondria (purple and green curves, respectively)
signi¯cantly increased the rate of O 
2 production
when compared to the control (CTRL) rate of O 
2
production. Figure 2(b) also demonstrates that
uncoupling the mitochondrial ETC with PCP
resulted in an abrupt and marked increase in the
rate of O 
2 production when compared to the KCN
treated cells. Enhanced °uorescence intensity was

evident right after addition of the metabolic agents,
and the intensity increased continuously in an exponential manner over time, demonstrating a
time-dependent ampli¯cation of ROS production.
To quantify the rate of O 
2 production in the
absence and presence of inhibitors of the ETC or the
uncoupler, PCP, (t ¼ 30–80 min), sigmoidal and
exponential empirical equations were ¯tted to
the experimental data (control and treated cells).
Figure 3 shows the initial slope of the intensity pro¯le
right after addition of the uncoupler/inhibitor.
These nonlinear ¯ts demonstrate that treating

1750018-7
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agent
PCP
ROT
AA
KCN
CTRL

(a)

151.5±18.3
56.6±1.8
82.1±2.7
56.5±4.8
-

36.6±3.7

(b)

Fig. 3. (a) Dynamic °uorescence intensity pro¯les over time of cells in the presence or absence of the uncoupler (PCP) or the
mitochondrial ETC complex inhibitors (ROT, AA, or KCN). Values are means  SE; n ¼ 6 for each treatment group. The solid
lines are exponential and sigmoidal ¯ts to the mean values of the agent-treated and control data. (b) The table shows the mean
values of initial slope (initial rates of superoxide production) of the exponential and sigmoidal ¯ts at t ¼ 30 min for each treatment
group and control. F.A.U., °uorescence arbitrary unit; ROT, rotenone; AA, antimycin A; KCN, potassium cyanide; PCP,
pentachlorophenol sodium salt.

the cells with an oxidizing agent (PCP 15 M), or
reducing agents (ROT 15 M, AA 1 M, and KCN
20 M) results in signi¯cantly larger increase in the
production (151:5  18:3,
initial rate of O 
2
56:6  1:8, 82:1  2:7, 56:5  4:8) at t ¼ 30 min
when compared to that of the control cells
(36:6  3:7). Presented values correspond to the
initial time (t ¼ 30 min) when the metabolic agents
were added. To evaluate for consistency and reproducibility of the results, a total of 48 wells of
PAECs were imaged, with n ¼ 6 for each of the
treated groups and the control. The slopes of the
¯tted functions were calculated at the time of
the administration of the agent for six FOVs per
group for the treated and control cells. The green
curve of Fig. 3 corresponds to the average pro¯le of
the PCP experiments, and it demonstrates the
fastest and greatest increase in the rate of O 
2
production (4:90  0:5) in uncoupled mitochondria.
The slopes of the intensity right after the addition of
mitochondrial metabolic modulators (t ¼ 30 min)
were compared statistically in Fig. 4, demonstrating
signi¯cant changes between treated groups versus
the control group. Increase in the slope intensity
pro¯le by a factor of 1:83  0:05 (orange curve,
Fig. 3 and orange bar, Fig. 4) re°ects the ROTinduced increase in the rate of O 
2 production from

complex I. The red and purple bars in Fig. 4 show
greater rates of O 
2 production by AA and KCN,
respectively, by a factor of 2:66  0:08 and 1:83 
0:14 compared to the control group.
To con¯rm our method for localizing the mitochondrion as the source of O 
2 production under

Fig. 4. Summary bar graphs show the slope of the °uorescence
intensity pro¯les right after the agent administration. Bar
graphs show the means  SE of the red °uorescence intensity
slopes (t ¼ 30 min) for the ¯ve groups of cells. Addition of
agents to PAECs (green, orange, red, and purple bars) resulted
in signi¯cant (  p < 0:05) increase in the rate of O 
2 production
when compared to the nontreated (control) PAECs (blue bar).
n ¼ 6/group.
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(a)

(b)

Fig. 5. (a) Mean  SE of °uorescence intensity pro¯les of O 
2 production over time in PAECs treated with PCP alone or PCP
with one of the ETC inhibitors; (b) Summary bar graphs show mean  SE of the slope ratio of the red °uorescence intensities for the
four treatment groups n ¼ 6/group.

metabolic stress conditions, a dual agent exposure
protocol was designed. This method was devised to
partition the O 
2 production from di®erent parts of
the ETC. After oxidizing the ETC with PCP, the
ETC was reduced with the di®erent ETC complex
inhibitors (complexes I, III and IV) to tease out
the complex/s responsible for the surge in O 
2
production when PCP fully oxidized the ETC.
The curves in Fig. 5 represent the pro¯les of mean
intensity in each time point for the corresponding
groups. The green curve displays PCP-induced intensity pro¯le compared to the orange, red, and
purple curves, which demonstrate the e®ects of the
addition of ROT, AA, and KCN to the PCP treated
cells, respectively. The SR was calculated for all
four groups, with n ¼ 6 per group. Bar graphs in
Fig. 5 show the means and SEM of the SR of the red
°uorescence intensity for each of the four groups of
cells. When compared to the addition of ROT
and AA (orange and red bars, respectively), the
addition of KCN to PCP-treated PAECs (purple
bar) resulted in a signi¯cant reduction (p ¼
9:8026e-5), 62.7%, in the rate of the °uorescence
intensity as compared to the °uorescence intensity
of PAECs treated with PCP alone (green bar). This
result shows that only KCN was able to signi¯production by the
cantly attenuate the O 
2
uncoupling agent PCP.
To provide further evidence that the surge in
production by PCP was mainly from mitoO 
2
chondria, the mitochondrial-targeted ROS scavenger, MitoTempol was used. The dual agent exposure

Fig. 6. Representative °uorescence intensity pro¯les in untreated cells (control) and PCP treated cells in the absence
and presence of the superoxide anion scavenger MitoTempol
over time. The arrows indicate the time MitoSOX (10 min),
PCP (30 min), and MitoTempol (35 min) were added to the
cells. F.A.U., °uorescence arbitrary unit; this panel shows that
MitoTempol reversed PCP-induced O 
2 production.

protocol was used to validate mitochondria as the
primary source of O 
2 production during real-time

O 2 oxidation of MitoSOX, using the uncoupler
PCP followed by MitoTempol. Figure 6 shows
°uorescence intensity pro¯les in untreated cells
(control; blue curve) and PCP treated cells in the
absence and presence of MitoTempol over time
(green and red curves, respectively). As observed
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previously, adding PCP at t ¼ 30 min markedly
production rate (compare green
increased O 
2
pro¯le with blue curve); adding MitoTempol at
t ¼ 35 min signi¯cantly decreased the rate of O 
2
production (red pro¯le versus green curve), and by
t ¼ 75 min, the PCP-induced O 
2 production was
completely abolished, reaching O 
2 levels similar to
the control cells (blue curve). The pink curve in
this panel shows that using MitoTempol decreased
the rate of O 
2 production when compared to the
control cells (blue curve). Comparison of the pink
and blue curves con¯rms that °uorescence measurement of MitoSOX oxidation re°ects the dynamic changes in mitochondrial O 
2 production in
real-time. This result further signi¯es that mitochondria are the primary source for O 
2 production
in the PAECs during metabolic stress. In addition,
we also observed that apocynin, a NOX inhibitor,
did not alter the trajectory of the mitochondrial
O 
2 production during metabolic stress (data not
shown), further con¯rming that the primary/major
source of ROS during metabolic modulation in the
PAECs is mitochondria.

4. Discussion
This study aimed to quantify mitochondrial O 
2
production dynamics in cultured endothelial cells
undergoing metabolic stress, utilizing °uorescent
time-lapse microscopy. Experimental protocols
were designed to (1) localize the source of the
mitochondrial O 
2 , (2) measure the changes in
mitochondrial O 
2 levels and rate of production, (3)
production
quantify transient behavior of O 
2
during disruption of the ETC to mimic pathological
ROS emission (production > scavenging). A major
¯nding of this study is that ETC inhibitors and
uncouplers, when given separately, induced expoproduction.
nential increase in the level O 
2
Complex IV seems to play a major role in
ROS production during uncoupled mitochondrial
respiration.
The mitochondria-speci¯c indicator MitoSOX
production. This
Red was used to monitor O 
2
probe has been validated by others21,24,25,27,29,40,41
and for selective detection of mitochondrial O 
2
production in endothelial cells.24,25,31 However, online loading of ECs with nanomolar MitoSOX and
real-time monitoring of mitochondrial O 
2
production have not been previously reported.

Although several recent studies have been
conducted with live cell imaging42 and with plate
reader assays,43 none of these studies provided realdynamic
time monitoring of mitochondrial O 
2
production over time. The novelty of our method is
dynamics in
the real-time monitoring of the O 
2
mitochondria, during targeted alteration of ETC
function over time. Our current study mainly
focused on mitochondrial sources of O 
2 , by compartmentalizing the °uorescent probe in mitochondria, while the other methods, including HPLC,44
provide only global cellular information at ¯xed
time-points. The other novelty of our study is loin the
calizing the primary source of the O 
2
uncoupled ETC. It is worth noting that most plate
reader-based assays have poor sensitivity and are
subject to artifacts.45,46 Use of plate reader systems
for real-time kinetic measurements is associated
with many pitfalls and limitations, including erroneous sustained increases in °uorescence, limited
sensitivity and lack of selectivity, and single cell
resolution. The HPLC method also has some limitations, including low throughput, and inability to
track real-time changes in intracellular and extracellular O 
2 levels.
The measurement of various ROS is dependent
on suitable techniques, which is currently hampered
by the lack of sensitive and speci¯c assays.4 Submicromolar MitoSOX is a sensitive and speci¯c
°uorescent marker for mitochondrial O 
2 and useful in monitoring the dynamic changes in O 
2 production during stress. MitoSOX, a cationic probe,
selectively targets and enters mitochondria because
of their strong negative m.4 This biophysical
attribute makes sub-micromolar/nanomolar MitoSOX a suitable dye to assess mitochondrial-derived
20
including PAECs.
O 
2 production in live cells,
The ETC drives electrons from reduced
coenzymes (NADH(H þ Þ and FADH2 Þ to O2, which
undergoes the complete reduction to H2O catalyzed
by complex IV. During the electron transfer, some
electrons escape from the ETC at discrete sites to

4
generate O 
2 . O 2 production is favored in general
by high m and large NADH(H þ Þ, or when
electron transfer is impeded by alteration in the
ETC complexes.6,47 In this scenario, a decrease in
ROS production would portend m depolarization due to enhanced electron transfer, as observed
with uncoupling agents. Paradoxically, though,
conditions have been reported in which mitochondrial uncoupling and m dissipation are
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associated with increased production of ROS.48 This
observation is consistent with our results which
show PCP, an uncoupling agent, increases O 
2
production (Figs. 2–4). According to the proposed
model of redox-optimized ROS balance by Aon
et al.,49 this apparent paradox might be explained
by the hypothesis that physiological signaling ROS
occurs within an optimized redox state, and oxidative stress can happen at the extreme of either reduction or oxidation of the ETC. Consistent with
this hypothesis, our results demonstrated higher
levels and rates of production in both the
O 
2
reduced (inhibited) and oxidized (uncoupled) ETC.
A plausible explanation is that the elevated levels of
initially overwhelm the scavenging potential
O 
2
of mitochondrial antioxidant system and leads to
excess ROS emission (oxidative stress).
Complexes I and III are fully reduced when they
are blocked with ROT and AA, respectively.
The highly reduced redox state creates a buildup of
electrons along the ETC, leading to forced electron
leak that reduces O2 to O 
2 anions; thus making
complexes I and III as major sites of O 
2 production
in the presence of ROT50–52 and AA.20,21,53–58 This
observation is consistent with our results that show
(Figs. 3 and 4) an increase in the intensity of red
°uorescence emitted from mitochondria after the
addition of rotenone or AA. KCN is an inhibitor of
the enzyme cytochrome c oxidase or complex
IV.59,60 The binding of cyanide to cytochrome c
prevents the transfer of electrons from the enzyme
to O2, creating a buildup of electrons in the ETC.
As a result, inhibiting complex IV increases ROS
production4,61–63 and decreases O2 availability for
cellular respiration (hypoxia). Our data show that
inhibition of O2 binding with complex IV leads to
both electron backup and availability of O2 to be
reduced to O 
2 , without the generation of H2O.
Moreover, inhibition of mitochondrial ETC by cyproduction at comanide possibly increases O 
2
plexes I and III.64–66
Pentachlorophenol (PCP) is a powerful uncoupler of oxidative phosphorylation and also induces
oxidative stress to cause mitochondrial damage.67–70 PCP dissipates the proton gradient by
consuming the proton motive force via increased
proton leak back into the matrix. A recent study
reported that PCP oxidizes the ETC and increase
the activity of complex I,71 leading to the production of more protons and transfer of more electrons
along the ETC. Lack of proton gradient for

phosphorylation and polarized m, activates a
mechanism to compensate for the uncoupling e®ect
of PCP, by increasing proton pumping and respiration, in an attempt to reestablish the proton
gradient. Ironically, the increase in activity of the
complexes in the uncoupled chain, increases electron transfer along the ETC, and as a result,
increases electron leak to O2 leading to O 
2 production.49,72–75 This notion is supported by our
observation that uncoupling respiration with PCP
led to the fastest and greatest increase (Fig. 3) in
the mitochondrial O 
2 production. The ¯nding also
suggests that the increased protonophoric e®ect of
the uncoupler (electron leak) leads to a feed-forward
mechanism that exacerbates ROS production.
Administration of the metabolic stressor/
modulators (PCP, KCN, AA, or ROT) in PAECs
production (Figs. 2
induces two phases of O 
2
and 3). The initial phase is marked by immediate
increase in O 
2 production following the addition of
metabolic agents (surge phase); this is followed by
smaller rate of O 
2 production (decrease in slope
intensity) and eventually reaches the steady-state
phase. This steady-state phase is consistent with the
view that increased O 
2 level may induce MnSOD
activity as a negative feedback mechanism to dismutate the excess O 
2 and therefore decrease the
production
over time76 as compared to
rate of O 
2
the early phase of the stress condition. The fast
dismutation of O 
2 by MnSOD also enhances the
time course to attain the steady-state. It is worth
noting that the oxidation of MitoSOX is 500 times
21
slower than the rate of O 
2 scavenging by SOD.

Therefore, less O 2 is available for oxidizing MitoSOX, which leads to a decrease or no change in
the rate of the O 
2 production at the later stage
of the imposed metabolic stress conditions
(Figs. 2(b) and 3(a)).
Figure 3 also exempli¯es the ¯ts of the nonlinear
empirical equations to the intensity pro¯les of the
treated and non-treated PAECs. These nonlinear
¯ts show that ETC uncoupling and inhibiting
involves an exponential up-regulation of O 
2 production, while the nontreated cells show sigmoidal
pro¯le. Having these nonlinear ¯ts of the intensity
pro¯les allows for quantifying important para
meters of O 
2 dynamics including O 2 production
rate, which is the slope of the ¯t in each time point
and the O 
2 level that is proportional to the intensity value of the ¯t at each time point. Moreover,
nonlinear ¯ts provide the time constant (T; the time
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point when the intensity level rises to 65% of the
ultimate value, b) of the exponential increase in the
mitochondrial O 
2 levels. We also used the slope of
the ¯t exactly after addition of the agent to quantify
the initial rate of O 
2 production after each treatment. The nonlinear ¯ts suggest that uncoupling of
the mitochondrial ETC by PCP leads to the fastest
rate of O 
2 production (bottom panel of Fig. 3) and
highest levels of O 
2 accumulation compared to the
inhibition of the ETC. A signi¯cantly higher slope
of the exponential ¯t for the PCP-treated cells
generation in the uncoupled
indicates faster O 
2
ETC. Moreover, the exponential ¯t shows higher
levels in PAECs with
levels of accumulated O 
2
uncoupled ETC, which is consistent with the studies of Aon et al.49
The rate of O 
2 productions was also assessed in
dual agent (combination of metabolic modulators)
protocols to identify the complexes that mediate the
uncoupling e®ect of PCP on O 
2 production, and
the scavenging potential of mitochondrial-targeted
productions from
scavenger (MitoTempol). O 
2
mitochondria are primarily from complexes (I, III,
and IV), distinguished by the use of speci¯c blockers
(see Materials and Methods) of the ETC complexes.
Of the three complexes targeted, only complex IV
blocker, KCN, signi¯cantly decreased the rate of
production induced by PCP. This suggests
O 
2
strongly that the uncoupling e®ect of PCP on O 
2
production is related to increased electron leak at
the ¯nal acceptor complex IV to O2, without generation of H2O. Thus, in the uncoupled mitochondria, the main source of O 
2 production is probably
associated with the oxidation of mitochondrial ETC
via complex IV. Therefore, a notable observation is
that in the PAECs, complex IV is a major site for
O 
2 production when mitochondrial respiration is
uncoupled.
Consistent with the redox-optimized ROS balance hypothesis, our method has the potential to
model redox as ROS modulator and con¯rm the
important role that redox modulation plays in
controlling ROS production and potentially, ROSmediated mitochondrial dysfunction and concomitant cellular injury. The single agent experiments
showed that reduction (inhibition) or oxidation
(uncoupling) of ETC leads to exponential increase
production, with more pronounced e®ect
in O 
2
in the presence of PCP (Fig. 3(a)). Therefore,
any shift toward oxidation or reduction leads to an
increase in the rate of O 
2 production. As Eq. (3)

shows, this ROS production is proportional to the
di®erence of the redox state (R) from its optimal
value (Ropt).
ROS  jR  Roptj:

ð3Þ

In addition, the dual agent experiments demonstrated the shift in the redox state towards oxidation by PCP, and the reversal of the O 
2 by KCN
suggests that the redox optimized balance could be
modulated by targeting speci¯c ETC complexes. In
this scenario, the redox state (R) of the uncoupled
ETC becomes more reduced after adding KCN and
moves toward optimal redox state and attenuates
ROS production. This is a conundrum! The relationship between ROS and redox state provided in
Eq. (3) attempts to resolve this conundrum. That is,
even though KCN potentially increases ROS production, paradoxically, in the presence of PCP,
it decreases the uncoupling e®ect on increased ROS
production.
Since mitochondria are the major source of O 
2
production during the uncoupling of respiration
with PCP, we also examined whether the initial
production was amenable to the
surge in O 
2
mitochondria-targeted ROS scavenger, MitoTempol. This agent is hitched to the cationic agent
TPPþ, which pulls the scavenger into mitochondria
where it acts as an e®ective SOD mimetic. The
scavenging in the
dynamic of mitochondrial O 
2
presence of MitoTempol (the growing space between the green and red pro¯les in Fig. 6) con¯rms
prothat the initial surge in mitochondrial O 
2
duction following uncoupling of respiration with
PCP is primarily mediated by deranged electron
transfer in the ETC. This is also consistent with the
observation that complex IV might be the source of
electron leak that contributes to the surge in O 
2
generation in the initial phase, i.e., when production
exceeds the scavenging potential of MnSOD. We
further veri¯ed that the primary source of the O 
2
anion during simulated metabolic stress is mitochondria, because the NOX inhibitor, apocynin,
did not alter the cellular ROS production (data not
shown).
In conclusion, we used a novel approach that
enables us to, for the ¯rst time to the best of our
knowledge, partition and quantify the dynamics of
production from ETC commitochondrial O 
2
plexes under di®erent simulated metabolic stress
conditions in intact live PAECs. Nanomolar MitoSOX, to minimize its toxic e®ects, was used to
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monitor the rate of mitochondrial O 
2 production
in the PAECs, which was attenuated by the
mitochondria-speci¯c ROS scavenger (MitoTempol). We believe this approach could have farreaching implications for assessment of ROS in
physiology and pathophysiology. Therefore, accurate detection of mitochondrial ROS would allow us
to establish a diagnostic tool for assessing the role of
mitochondrial oxidative stress in the pathogenesis
of diseases.
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5.

Limitations

We relied on the concept that MitoSOX is oxidized
by O 
2 and the oxidation product becomes highly
°uorescent upon subsequent binding to mitochondrial DNA over time.21 It is possible that as a
cationic molecule, MitoSOX uptake into mitochondria can also contribute to direct ROS production by depolarizing m. However, the ROS
generated in this case was miniscule when compared to the ROS produced from modulating ETC
complexes. While nanomolar MitoSOX (used in
this study) had no adverse e®ects,42 we recommend
a lower nanomolar concentration (200 nM) of
production for longer
MitoSOX to study O 
2
durations.
It should also be noted that MitoSOX uptake
increases 10 fold for every 60 mV increase in
m.21,77 Since m decreases in the presence of
uncoupler78,79 and ETC inhibitors,78,80 the decrease
in m could impede the uptake of MitoSOX.
Therefore, the °uorescence intensities presented
could be an underestimate for the levels of the ROS
in the inhibited and uncoupled ETC.
Interaction of O 
2 and MitoSOX is also a®ected
by the pharmacokinetics of MitoSOX and its binding properties. The initial phase of the intensity
pro¯le shows a greatly enhanced °uorescence due to
binding of the oxidized MitoSOX to mitochondrial
DNA. In the steady state phase of the °uorescence
recording, the steady-state signal pro¯le can be
possibly due to binding of oxidized MitoSOX to
nuclei, which results in apparent nuclear and nucleolar localization (Fig. 2(a)). Due to nuclei
binding of MitoSOX and thus, the subsequent
diminished mitochondrial uptake of the °uorescent
probe, the °uorescence intensity of the mitochondrial compartment becomes saturated and after a
while reaches the ¯nal level.
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